Kiwon lafiya, Shirye-shirye
Sinekod - umarnin don amfani da
pharmacological effects
Sinekod, umarnin don yin amfani da abin da aka nuna a kasa, - ba narcotic antitussive pharmaceutical wakili kai tsaye mataki. A abun da ke ciki ya ƙunshi wani abu sinekoda butamirata. Da miyagun ƙwayoyi yana da wani tarewa mataki a kan tari cibiyar dake a cikin medulla oblongata. A daidai wannan lokaci, shi ya jaddada m, sinekod ba raunanar da numfashi aiki.
Bayan antitussive mataki sinekod bronchodilatory kuma ma yana da wasu antiinflammatory mataki. Da miyagun ƙwayoyi ne sun fi mayar da inganta oxygenation na jini da kuma spirometry. Lokacin karbar na baki da miyagun ƙwayoyi ne hanzari tunawa da hanji mucosa. Butamirata zuwa babban mataki saboda jini gina jiki abubuwa. Cincirindo a cikin jini jini sinekoda lura a cikin rabin awa bayan gwamnati. A cikin jiki, da miyagun ƙwayoyi metabolism take kaiwa ga samuwar na aiki metabolites pharmacological mataki. Hydrolysis sinekoda za'ayi a cikin jini. A sakamakon metabolites ne kama da butamirata pharmacological aiki.
Da miyagun ƙwayoyi ba tara a cikin jiki, da maimaita yin amfani da miyagun ƙwayoyi ba mai sãkẽwa ba da pharmacokinetics. Sinekoda rabin rayuwa ne 6 hours. Excreted yafi by kodan kamar yadda metabolites ko canzawa.
alamomi
Sinekod amfani ga m bayyanuwar nonproductive tari na daban-daban asalin, ciki har da m da bushe coughs a lokacin pertussis tari Club, bushe tari a raunuka na numfashi fili. Haka kuma an yi amfani da su kashe da tari reflex a lokacin bincike da karatu (bronchoscopy) da kuma tiyata.
dosing
Sinekod rika dauka kafin cin abinci, droplets za a iya narkar da a karamin girma na ruwa. A hanya na lura da kashi nada likita akayi daban-daban.
Sinekod-syrup, umarnin don amfani da
Marasa lafiya shekaru 3-6 shekaru yawanci 5 ml sinekoda sau uku a lokacin da rana. Marasa lafiya shekaru 6-12 shekaru - 10 ml sau uku a rana. 12 ko fiye da shekaru - 15 ml sau uku a rana. Manya - 15 ml, uku ko sau hudu a kullum. Lokacin da dosing syrup shawarar yin amfani da aunawa hula.
Sinekod - umarnin don baka amfani
Yara miyagun ƙwayoyi wajabta, a kanku fara a watanni biyu na shekaru. 2 months - 1 shekara: 10 saukad - sau hudu a rana.
Bayan shekara guda na shekaru kashi ƙaruwa. Daga daya zuwa shekara uku: 13-15 saukad - sau hudu a rana.
Bayan shekara uku da haihuwa da aka yarda a kalla kashi na miyagun ƙwayoyi "Sinekod". Umarnin ga marasa lafiya girmi shekaru 3, matasa da kuma manya: 25 saukad da sau hudu a ko'ina cikin yini.
illa
Jiyya tare da wannan magani na iya haifar da marasa lafiya wadannan illa: dizziness, ciwon kai, gajiya, tashin zuciya, take hakki na kujera, itchy fata, rash, urticaria.
contraindications
Lokacin da mutum ji na ƙwarai to gyara daga cikin miyagun ƙwayoyi. na huhu hemorrhage. a cikin ta farko trimester ciki. Har ila yau, da syrup an contraindicated a cikin yara kasa da shekaru uku da shekaru. saukad (da os) suna contraindicated ga yara yan kasa da shekaru uku da watanni.
ciki
Sinekod contraindicated a mata a lokacin farko da trimester. A baya lokaci na ciki da miyagun ƙwayoyi da ake amfani ne kawai a kan takardar sayen magani. A halin yanzu, bayanai a kan kasafi na sinekoda nono madara ne ba samuwa. A nada butamirata lactation bada shawarar a yanke shawara a kan ƙarshe na nono-ciyar.
Yawan abin sama "Sinekod"
Guide yayi kashedin cewa overdosing iya haifar da wadannan effects: tashin zuciya da amai, illa hanji aiki, drop a jini, drowsiness, juwa ko jiri, kuma asarar sani. Idan yawan abin sama yi ciki lavage, sanya chelators. Har ila yau nada osmotic laxatives da kwayoyi ya kula da numfashi tsarin da zuciya.
Da miyagun ƙwayoyi zo a cikin hanyar:
Syrup - vials sanya daga gilashi shaded (200 ml), hada da - daya girma vial hula. Saukad da na baka gwamnati - vials sanya daga gilashi shaded (20 ml).
ajiya yanayi
Sinekod adana a bushe wuri, zazzabi - 15-30 ° C. Storage rai - ba fiye da shekaru 5. Bijiro da batun kafa abubuwa na samfurin: 1 cm3 droplet ƙunshi 5 MG butamirata citrate. adjuvants + ethyl barasa. 10 cm3 na syrup ƙunshi 15 MG butamirata citrate. sababbin shiga.
Similar articles
Trending Now